152 related articles for article (PubMed ID: 12010908)
21. In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis.
Lebeche D; Kaprielian R; del Monte F; Tomaselli G; Gwathmey JK; Schwartz A; Hajjar RJ
Circulation; 2004 Nov; 110(22):3435-43. PubMed ID: 15557376
[TBL] [Abstract][Full Text] [Related]
22. Cardiac hypertrophy: sorting out the circuitry.
McKinsey TA; Olson EN
Curr Opin Genet Dev; 1999 Jun; 9(3):267-74. PubMed ID: 10377279
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
[TBL] [Abstract][Full Text] [Related]
24. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
25. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
Fiedler B; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
[TBL] [Abstract][Full Text] [Related]
26. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
[TBL] [Abstract][Full Text] [Related]
27. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
[TBL] [Abstract][Full Text] [Related]
28. Calcineurin anchoring and cell signaling.
Dodge KL; Scott JD
Biochem Biophys Res Commun; 2003 Nov; 311(4):1111-5. PubMed ID: 14623297
[TBL] [Abstract][Full Text] [Related]
29. Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes.
Zobel C; Kassiri Z; Nguyen TT; Meng Y; Backx PH
Circulation; 2002 Oct; 106(18):2385-91. PubMed ID: 12403671
[TBL] [Abstract][Full Text] [Related]
30. IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling.
Jiang DS; Wei X; Zhang XF; Liu Y; Zhang Y; Chen K; Gao L; Zhou H; Zhu XH; Liu PP; Bond Lau W; Ma X; Zou Y; Zhang XD; Fan GC; Li H
Nat Commun; 2014; 5():3303. PubMed ID: 24526256
[TBL] [Abstract][Full Text] [Related]
31. Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure.
Rothermel BA; Berenji K; Tannous P; Kutschke W; Dey A; Nolan B; Yoo KD; Demetroulis E; Gimbel M; Cabuay B; Karimi M; Hill JA
Physiol Genomics; 2005 Sep; 23(1):18-27. PubMed ID: 16033866
[TBL] [Abstract][Full Text] [Related]
32. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
Wilkins BJ; Molkentin JD
Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
[TBL] [Abstract][Full Text] [Related]
33. Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling.
Chakkalakal JV; Stocksley MA; Harrison MA; Angus LM; Deschenes-Furry J; St-Pierre S; Megeney LA; Chin ER; Michel RN; Jasmin BJ
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7791-6. PubMed ID: 12808150
[TBL] [Abstract][Full Text] [Related]
34. Activation of the calcineurin/NFAT signalling cascade starts early in human hypertrophic myocardium.
Diedrichs H; Hagemeister J; Chi M; Boelck B; Müller-Ehmsen J; Schneider CA
J Int Med Res; 2007; 35(6):803-18. PubMed ID: 18034994
[TBL] [Abstract][Full Text] [Related]
35. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
Takimoto E; Champion HC; Li M; Belardi D; Ren S; Rodriguez ER; Bedja D; Gabrielson KL; Wang Y; Kass DA
Nat Med; 2005 Feb; 11(2):214-22. PubMed ID: 15665834
[TBL] [Abstract][Full Text] [Related]
36. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
37. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy.
Shimoyama M; Hayashi D; Takimoto E; Zou Y; Oka T; Uozumi H; Kudoh S; Shibasaki F; Yazaki Y; Nagai R; Komuro I
Circulation; 1999 Dec; 100(24):2449-54. PubMed ID: 10595959
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity.
Ruggiero A; Chen SN; Lombardi R; Rodriguez G; Marian AJ
Cardiovasc Res; 2013 Jan; 97(1):44-54. PubMed ID: 22987565
[TBL] [Abstract][Full Text] [Related]
39. TAK1 Regulates Myocardial Response to Pathological Stress via NFAT, NFκB, and Bnip3 Pathways.
Li L; Chen Y; Li J; Yin H; Guo X; Doan J; Molkentin JD; Liu Q
Sci Rep; 2015 Nov; 5():16626. PubMed ID: 26564789
[TBL] [Abstract][Full Text] [Related]
40. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure.
Haq S; Choukroun G; Lim H; Tymitz KM; del Monte F; Gwathmey J; Grazette L; Michael A; Hajjar R; Force T; Molkentin JD
Circulation; 2001 Feb; 103(5):670-7. PubMed ID: 11156878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
